TetraLogic Pharmaceuticals Corporation, a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics in oncology and infectious diseases. Its clinical-stage product candidate, Birinapant, is in Phase II clinical trial administered with azacitidine for the treatment of myelodysplastic syndromes. The company's pre-clinical programs also comprise Phase I/II open-label, non-randomized clinical trial of Birinapant administered with conatumumab in third-line ovarian cancer; and Phase I clinical trial of Birinapant in subject with chronic Hepatitis B virus. In addition, its clinical-stage product candidate, suberohydroxamic acid 4-methoxycarbonyl phenyl ester, is in Phase II clinical trial for the treatment of early-stage cutaneous T-cell lymphoma. The company has collaboration with Amgen, Inc. for exploring the combination of Birinapant administered with Amgen's TRAIL receptor agonist antibody, conatumumab. The company was formerly known as Gentara Corporation and changed its name to TetraLogic Pharmaceuticals Corporation in January 2006. TetraLogic Pharmaceuticals Corporation was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
ANADIGICS, Inc. designs, manufactures, and sells radio frequency (RF) semiconductor solutions for infrastructure and mobile communications, and data transmission markets. The company's product portfolio includes line amplifiers, reverse path amplifiers, front-end integrated circuits (FEICs), and power amplifiers (PAs). Its CATV solutions consist of line amplifiers, reverse path amplifiers, and other RF products that provide the critical link within CATV infrastructure communications networks, as well as CPE devices, such as set-top boxes and cable modems. The company's Wi-Fi infrastructure products comprise PAs and FEICs, which enable wireless connectivity for infrastructure and multimedia applications, including access points, routers, media gateways, and set-top boxes. Its wireless infrastructure solutions consist of PAs that are crucial components in 3G and 4G small-cell base stations, such as picocells, enterprise-class femtocells, and CPE devices, which help carriers expand broadband network coverage and support data transmission. The company's Wi-Fi mobile products comprise FEICs and PAs that are designed to enable Wi-Fi connectivity in smartphones, tablets, notebooks, and gaming systems. Its cellular products include PAs, which enable 3G and 4G wireless connectivity in mobile handsets, smartphones, tablets, and notebooks. The company also provides foundry services, including manufacture and test of VCSEL devices for various sensing applications. It sells its products through direct sales, as well as through independent manufacturers' representatives and distributors. ANADIGICS, Inc. was founded in 1984 and is headquartered in Warren, New Jersey.
Ardelyx, Inc. discovers, develops, and commercializes minimally-systemic small molecule therapeutics for the gastrointestinal (GI) tract to treat cardio-renal, GI, and metabolic diseases. Its lead product candidate is tenapanor, a small molecule NHE3 inhibitor, which has completed Phase 2b clinical trial for the treatment of patients with constipation-predominant irritable bowel syndrome and hyperphosphatemic patients with chronic kidney disease on dialysis, as well as Phase 2a clinical trial in patients with late-stage chronic kidney disease. The company's discovery and lead development programs that are in research phase include RDX002 NaP2b inhibitor for hyperphosphatemia; RDX009 TGR5 agonists for inflammatory bowel disease, short bowel syndrome, and non-alcoholic steatohepatitis; and RDX013 for hyperkalemia. It has a collaboration partnership agreement with AstraZeneca AB for the development and commercialization of tenapanor. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. Ardelyx, Inc. was founded in 2007 and is headquartered in Fremont, California.
Interphase Corporation, an information and communications technology company, provides embedded computing solutions, engineering design services, and contract manufacturing services in North America, the Pacific Rim, and Europe. The company's network connectivity products include OC-3/STM-1 asynchronous transfer mode network interface cards (NICs), Ethernet NICs, and T1/E1 communication controllers that primarily support SS7 signaling; interworking products comprise OC-3/STM-1 interworking modules, and broadband access gateway and media converters; and gigabit Ethernet (GigE) and 10 GigE packet processors. It also provides penveu, a handheld device primarily for use in the education market that adds interactivity to the installed base of projectors and large screen displays, making any flat surface, from pull down screens to HDTVs, an interactive display system. In addition, the company offers engineering design services, such as specifications gathering; program management; electrical, mechanical, and thermal design; wireless services design for cellular, Wi-Fi, Bluetooth, and other services; mechanical enclosure design; software design for drivers and applications; application software porting and integration; rapid prototyping; and manufacturability and testability design, product design verification testing, product certification, and production test development. Further, it offers electronics manufacturing services comprising supply chain management, custom branding and control, production assembly, system integration, testing and delivery, and inventory management and logistics services. The company sells its products and services to telecom equipment and server manufacturers, as well as to the electronics industry through its direct sales force, manufacturers' representatives, value-added distributors, tradeshows, and Web and social media tools. Interphase Corporation was founded in 1974 and is headquartered in Carrollton, Texas.
Skullcandy Inc. designs, markets, and distributes audio and gaming headphones, earbuds, speakers, and other accessories under the Skullcandy, Astro Gaming, and 2XL brands in the United States and internationally. It sells its products through specialty, consumer electronics, sporting goods, mobile phones, and big box retailers; and third party distributors, as well as through its skullcandy.com, skullcandy.tv, ca.skullcandy.com, eu.skullcandy.com, uk.skullcandy.com, 2xl.com, astrogaming.com, astrogaming.co.uk, and astrogaming.fr Websites. The company was founded in 2003 and is headquartered in Park City, Utah.
CoLucid Pharmaceuticals, Inc. is a United States-based clinical-stage biopharmaceutical company that develops a product candidate, Lasmiditan, for the treatment of central nervous system (CNS) disorders. The Company develops oral Lasmiditan for the acute treatment of migraine headaches in adults and intravenous Lasmiditan for the acute treatment of unspecified headache pain in adults in emergency room and other urgent care settings. Its Lasmiditan is used for the acute treatment of migraine headaches in adults without the vasoconstrictor activity associated with previous generations of migraine therapies. The Company has completed seven clinical studies for Lasmiditan, including a TQTc study and a Phase IIb study treating a single migraine attack in around 391 patients.
Town Sports International Holdings, Inc., together with its subsidiaries, owns and operates fitness clubs in the Northeast and Mid-Atlantic regions of the United States. It offers special purpose rooms for group fitness classes; and other exercise programs, as well as accommodates cardiovascular and strength-training equipment. The company also provides amenities, including swimming pools, racquet and basketball courts, babysitting services, and pro-shops; and fee-based programs services, which comprise personal training, small group training, children's programs, and other signature classes for adult members. It sells its memberships through direct sales, corporate and group sales, and call center, as well as through its online Website. As of December 31, 2014, the company operated 158 fitness clubs comprising 107 New York Sports Clubs, 30 Boston Sports Clubs, 13 Washington Sports Clubs, 5 Philadelphia Sports Clubs, 3 clubs located in Switzerland, and 1 BFX Studio. Town Sports International Holdings, Inc. was founded in 1973 and is based in New York, New York.
Noodles & Company develops and operates fast casual restaurants in the United States. It offers cooked-to-order dishes, including noodles and pasta, soups, salads, sandwiches, and appetizers. As of December 30, 2014, the company operated 439 restaurants comprising 386 company-owned and 53 franchised locations, across 32 states and the District of Columbia. Noodles & Company was founded in 1995 and is based in Broomfield, Colorado.
Crestwood Equity Partners LP provides midstream solutions to customers in the crude oil, natural gas liquids (NGLs), and natural gas sectors of the energy industry in the United States. It operates through three segments: Gathering and Processing; Storage and Transportation; and NGL and Crude Services. The Gathering and Processing segment engages in the gathering, processing, treating, compression, transportation, and sale of natural gas; and the delivery of natural gas liquids to producers in unconventional shale plays and tight-gas plays in West Virginia, Wyoming, Texas, Arkansas, New Mexico, and Louisiana. The Storage and Transportation segment offers natural gas storage and transportation services to producers, utilities, and other customers. This segment owns and operates natural gas storage facilities with approximately 79.3 billion cubic feet of natural gas storage capacity in New York and Pennsylvania. The NGL and Crude Services segment provides NGL and crude oil gathering, storage, marketing, and transportation services to producers, refiners, marketers, and other customers; and produces and sells salt products. Crestwood Equity GP LLC serves as the general partner of Crestwood Equity Partners LP. The company was formerly known as Inergy L.P. and changed its name to Crestwood Equity Partners LP in October 2013. The company is headquartered in Houston, Texas. Crestwood Equity Partners LP is a subsidiary of Crestwood Holdings LLC.
Westlake Chemical Partners LP focuses on producing and selling ethylene. It also sells ethylene co-products, including propylene, crude butadiene, pyrolysis gasoline, and hydrogen directly to third parties on either a spot or contract basis. The company was founded in 2014 and is headquartered in Houston, Texas. Westlake Chemical Partners GP LLC serves as the general partner of the company.